Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;27(4):528-532.
doi: 10.18553/jmcp.2021.27.4.528.

The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder

Jeffrey A Tice  1 , Melanie D Whittington  2 , Jonathan D Campbell  2 , Steven D Pearson  2
Affiliations

The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder

Jeffrey A Tice et al. J Manag Care Spec Pharm. 2021 Apr.

Abstract

DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICER's annual policy summit is supported by dues from AbbVie, Aetna, America's Health Insurance Plans, Anthem, Alnylam, AstraZeneca, Biogen, Blue Shield of CA, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Evolve Pharmacy, Express Scripts, Genentech/Roche, GlaxoSmithKline, Harvard Pilgrim, Health Care Service Corporation, HealthFirst, Health Partners, Humana, Johnson & Johnson (Janssen), Kaiser Permanente, LEO Pharma, Mallinckrodt, Merck, Novartis, National Pharmaceutical Council, Pfizer, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, uniQure, and United Healthcare. Whittington, Campbell, and Pearson are employed by ICER. Tice reports contracts to his institution, University of California, San Francisco, from ICER during the conduct of this study.

PubMed Disclaimer

Conflict of interest statement

Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICER’s annual policy summit is supported by dues from AbbVie, Aetna, America’s Health Insurance Plans, Anthem, Alnylam, AstraZeneca, Biogen, Blue Shield of CA, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Evolve Pharmacy, Express Scripts, Genentech/Roche, GlaxoSmithKline, Harvard Pilgrim, Health Care Service Corporation, HealthFirst, Health Partners, Humana, Johnson & Johnson (Janssen), Kaiser Permanente, LEO Pharma, Mallinckrodt, Merck, Novartis, National Pharmaceutical Council, Pfizer, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, uniQure, and United Healthcare.

Whittington, Campbell, and Pearson are employed by ICER. Tice reports contracts to his institution, University of California, San Francisco, from ICER during the conduct of this study.

References

    1. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559-74. - PubMed
    1. Centers for Disease Control and Prevention. Provisional drug overdose death counts. 2018. Accessed March 4, 2021. https://www.cdc.goy/nchs/nvss/vsrr/drug-overdose-data.htm
    1. U.S. Department of Health and Human Services. National opioid crisis. 2019. Accessed March 4, 2021. http://www.hhs.gov/opioids
    1. Centers for Disease Control and Prevention. Overdose deaths accelerating during COVID-19. Updated December 18, 2020. Accessed March 4, 2021. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
    1. Council of Economic Advisors. The full cost of the opioid crisis: $2.5 trillion over four years. October 28, 2019. Accessed March 4, 2021. https://trumpwhitehouse.archives.gov/articles/full-cost-opioid-crisis-2-...

Publication types